| Literature DB >> 31625792 |
Yong Liu1, Xichao Mo2, Xiaxia Yu3, Jinxin Wang1, Jinfei Tian1, Jun Kuang4, Jie Peng2.
Abstract
China has a shocking number of tetanus cases in the world, but little research has investigated doctors' knowledge of and practices in tetanus prophylaxis, especially tetanus vaccination. To this end, we conducted a pilot study on 197 emergency doctors using a mixed method of web-based (163; 82.8%) and paper-based (34; 17.2%) surveys. There was no difference between the two groups except for the percentage of doctors receiving a tetanus booster in the past 10 years and the responses to question 11. Surprisingly, only 28.9% of doctors had received formal training on tetanus immunization and only 21.3% had themselves received a tetanus vaccine booster in the past 10 years. Furthermore, only 14.2% of the respondents confirmed the availability of the tetanus vaccine in their respective institutions. Finally, the correct rates and Tetanus-immune-globulin (TIG)-only option rates for questions 11-15 were unsatisfactory. Our results showed that most emergency doctors' knowledge and practices strayed from the recommendations of Advisory Committee on Immunization Practices (ACIP): 1) TIG alone for most trauma patients instead of vaccine was an overused treatment approach. 2) Most of the emergency doctors lacked formal training on and knowledge of tetanus vaccination. 3) Even the emergency doctors themselves were not properly vaccinated. 4) The tetanus vaccine was only available in a small number of the respondents' institutions. The findings of this study suggest an urgent need to improve this dire situation.Entities:
Keywords: Knowledge and practices; emergency doctors; tetanus immune globulin; tetanus prevention; tetanus vaccine
Year: 2019 PMID: 31625792 PMCID: PMC7062443 DOI: 10.1080/21645515.2019.1653745
Source DB: PubMed Journal: Hum Vaccin Immunother ISSN: 2164-5515 Impact factor: 3.452
Background characteristics of the study population.
| Characteristics | TotalN = 197 | Online surveyN = 163 | Paper surveyN = 34 | |
|---|---|---|---|---|
| Gender | 0.306 | |||
| Male | 167(84.8%) | 136 (83.4%) | 31 (91.2%) | |
| Female | 30(15.2%) | 27 (16.6%) | 3 (8.8%) | |
| Age group (years old) | 0.168 | |||
| 20–30 | 42(21.3%) | 39 (23.9%) | 3 (8.8%) | |
| 30–40 | 81(41.1%) | 65 (39.9%) | 16 (47.1%) | |
| 40–50 | 61(31.0%) | 50 (30.7%) | 11 (32.4%) | |
| >50–60 | 13(6.6%) | 9 (5.5%) | 4 (11.8%) | |
| Organization type | 0.534 | |||
| Primary hospital | 10(5.1%) | 9 (5.5%) | 1 (3.0%) | |
| Non-primary hospital | 187(94.9) | 154(94.5) | 33(97.0%) | |
| Education level | 0.532 | |||
| Less than 5-year college | 17(8.6%) | 15 (9.2%) | 2 (5.9%) | |
| 5-year or more college | 180(91.4%) | 148 (90.8%) | 32 (94.1%) |
Non-primary hospitals include secondary hospitals, tertiary hospitals, and international clinics.
Tetanus vaccination training, doctors receiving a tetanus booster and tetanus vaccine supply.
| Characteristics | TotalN = 197 | Online surveyN = 163 | Paper surveyN = 34 | |
|---|---|---|---|---|
| Tetanus vaccination training | 57(28.9%) | 49 (30.1%) | 8 (23.5%) | 0.536 |
| Doctors receiving a tetanus booster in the past 10 years | 42(21.3%) | 30 (18.4%) | 12 (35.3%) | 0.029 |
| Supply of tetanus vaccine | 28(14.2%) | 22 (13.5%) | 6 (17.6%) | 0.528 |
The knowledge and practice patterns of emergency doctors in mainland China in terms of tetanus prophylaxis in trauma patients.
| Characteristics | Total | Online survey | Paper survey | |
|---|---|---|---|---|
| 1.10 ± 0.86 | 1.05 ± 0.87 | 1.35 ± 0.77 | 0.06 | |
| Correct (Tdap or Td4 without TIG) | 16 (8.1%) | 7 (4.3%) | 9 (26.5%) | 0.001 |
| Only TIG or immunoglobin if allergy | 137 (69.5%) | 124 (76.1%) | 13 (38.2%) | |
| Correct (only wound care) | 81 (41.1%) | 67 (41.1%) | 14 (41.2%) | 0.994 |
| Only TIG or immunoglobin if allergy | 69 (35.0%) | 62 (38.0%) | 7 (20.1%) | |
| Correct (TAT or TIG with vaccine) | 83 (42.1%) | 73 (44.8%) | 10 (29.4%) | 0.099 |
| Only TIG or immunoglobin if allergy | 98 (49.7%) | 83 (50.9%) | 15 (44.1%) | |
| Correct (only wound care) | 24(12.2%) | 17 (10.4%) | 7 (20.6%) | 0.144 |
| Only TIG or immunoglobin if allergy | 100(50.8%) | 87 (53.4%) | 13 (38.2%) | |
| Correct (tetanus-containing vaccine) | 24 (12.2%) | 17 (10.4%) | 7 (20.6%) | 0.144 |
| Only TIG or immunoglobin if allergy | 98(49.7%) | 84(51.5%) | 14(41.2%) |
Question 11: Clean and minor wound and receiving incomplete DTaP series for patients aged 11 years and older
Question 12: Clean and minor wound and receiving complete DTaP series for patients aged 11 years and older
Question 13: Dirty or deep wounds but with unclear history of tetanus vaccine
Question 14: Dirty or deep wounds and complete 3-dose primary series with an interval of 5 years or more from last dose
Question 15: Dirty or deep wounds and complete 3-dose primary series (any tetanus-containing vaccine) with an interval less than 5 years from last dose
Tetanus prophylaxis guidelines.
| For Children Aged 6 Weeks through 6 Years | ||||
|---|---|---|---|---|
| Vaccination history | Clean and minor wound | TIG? | All other wounds | TIG? |
| Incomplete DTaP series | Give DTaP (if minimum interval met since last | No | Give DTaP (if minimum interval met since last dose) | Yes |
| Complete DTaP series | No further action required | No | No further action required | No |
| For Children Aged 7 through 10 Years | ||||
| Vaccination history | Clean and minor wound | TIG? | All other wounds | TIG? |
| Incomplete DTaP series | Give Tdap (preferred) or Td | No | Give Tdap (preferred) or Td4 | Yes |
| Complete DTaP series with an interval of 5 years or more from last dose | No further action required | No | Aged 7–9 years: Give Td;aged 10 years: Give Tdap (preferred) or Td4 | No |
| Complete DTaP series with an interval of less than 5 years from last dose | No further action required | No | No further action required | No |
| For Persons Aged 11 Years and Older | ||||
| Vaccination history | Clean and minor wound | TIG? | All other wounds | TIG? |
| Incomplete 3-dose primary series (any tetanus-containing vaccine) with an interval of 5 years or more from last dose | Give Tdap (preferred) or Td4 | No | Give Tdap (preferred) or Td | Yes |
| Complete 3-dose primary series with an interval of 5 years or more from last dose | No further action required for wound care | No | Give Tdap (preferred) or Td | No |
| Complete 3-dose primary series (any tetanus-containing vaccine) with an interval less than 5 years from last dose | No further action required for wound care | No | No further action required for wound care | No |
| TIG: Tetanus immune globulin | ||||
| Univariate regression | Multivariate logistic regression | ||||||
|---|---|---|---|---|---|---|---|
| Independent variable | OR (95% CI) | P | aβ (95% CI) | P | OR (95% CI) | P | |
| Gender | Male | 1 | 0.045b | 0.446(−1.000–0.992) | 0.109 | 1 | 0.504 |
| Female | 1.977(1.014–3.856) | 1 | 1.360(0.552–3.351) | ||||
| Age group (years old) | 20–30 | 1 | 0.689 | 1 | 0.468 | 1 | 0.198 |
| 30–40 | 0.832(0.367–1.883) | −0.194(−0.862–0.474) | 0.751(0.322–1.751) | ||||
| 40–50 | 0.727(0.303–1.747) | −0.325(−1.029–0.379) | 0.653(0.262–1.630) | ||||
| More than 50 | 0.406(0.078–2.096) | −0.864(−0.979–0.250) | 0.325(0.059–1.800) | ||||
| Education | Less than 5-year college | 0.848(0.284–2.535) | 0.768 | −0.027(−0.919–0.865) | 0.952 | 0.808(0.254–2.572) | 0.718 |
| 5-year or more college | 1 | ||||||
| Hospital type | Joint venture hospital | 2.17(1.100,4.688) | 0.047b | 0.451 | 0.175 | 1.92(0.683,5.445) | 0.228 |
| Non-joint venture hospital | 1 | 1 | 1 | ||||
| Training | Yes | 0.874(0.430–1.776) | 0.709 | 0.003(−0.550–0.555) | 0.993 | 0.872(0.393–1.935) | 0.737 |
| No | 1 | ||||||
| WHO guideline | Yes | 1.163(0.600–2.256) | 0.654 | 0.080(−0.449–608) | 0.767 | 1.326(0.636–2.763) | 0.452 |
| No | 1 | ||||||
aLine regression
bwith a P value <0.05